Login
$BCDA
$0.90 -$0.02 (2.33%) After hours

$BCDA 3 SEC Filings

Filed On Filing
10 Dec 2025 Form 3: Slosman Marvin, Director

No securities owned

19 Oct 2023 Form 3: Facteau Bill, Director

No securities owned

19 Jan 2021 Form 3: Zsebo Krisztina M, Director

No securities owned

19 Nov 2020 Form 3: Gillis Edward M, Senior Vice President, Devices
26 Feb 2020 Form 3: Blank Andrew Scott, Director

Holds 116,667 shares of Common Stock

26 Feb 2020 Form 3: Allen Jim L., Director

Holds 516,329 shares of Common Stock

03 Jan 2019 Form 3: Stertzer Kimberly, 10% owner

Holds 4,278,274 shares of Common Stock

03 Jan 2019 Form 3: Stertzer Family Trust, 10% owner

Holds 4,278,274 shares of Common Stock

26 Oct 2016 Form 3: Tessler Allan R, Director

Holds 6,965,106 shares of Common Stock

26 Oct 2016 Form 3: Stertzer Simon H, Director

Holds 30,956,710 shares of Common Stock

26 Oct 2016 Form 3: Allen Richard T, VP, Quality Assurance

Holds 0 shares of No securities beneficially owned

26 Oct 2016 Form 3: Altman Peter, Director

Holds 8,338,109 shares of Common Stock

26 Oct 2016 Form 3: Duckers Eric, Chief Medical Officer

Holds 0 shares of No securities beneficially owned

26 Oct 2016 Form 3: Krasno Richard M, Director

Holds 0 shares of No securities beneficially owned

26 Oct 2016 Form 3: McClung David, VP of Finance

Holds 0 shares of No securities beneficially owned

26 Oct 2016 Form 3: Moyes Jay M, Director

Holds 159,009 shares of Common Stock

26 Oct 2016 Form 3: Pesta Phil, VP, Operations

Holds 0 shares of No securities beneficially owned

26 Oct 2016 Form 3: Pfenniger Richard C Jr, Director

Holds 600,000 shares of Common Stock

26 Oct 2016 Form 3: Quertermous Thomas, Director

Holds 1,305,466 shares of Common Stock

26 Oct 2016 Form 3: Fernandez Fernando L, Director

Holds 0 shares of No securities beneficially owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support